Survival benefit, disease progression and quality-of-life outcomes of abiraterone acetate plus prednisone versus docetaxel in metastatic hormone-sensitive prostate cancer: A network meta-analysis
Titel:
Survival benefit, disease progression and quality-of-life outcomes of abiraterone acetate plus prednisone versus docetaxel in metastatic hormone-sensitive prostate cancer: A network meta-analysis
Auteur:
Feyerabend, Susan Saad, Fred Li, Tracy Ito, Tetsuro Diels, Joris Van Sanden, Suzy De Porre, Peter Roiz, Julie Abogunrin, Seye Koufopoulou, Maria Fizazi, Karim